Katy Beckermann
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 18
- Oncology 12
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Hans J. Hammers (8 shared papers)Toni K. Choueiri (2 shared papers)Daniel Yick Chin Heng (2 shared papers)Nicholas J. Vogelzang (3 shared papers)Naomi B. Haas (4 shared papers)Laurence Albigès (5 shared papers)Brian I. Rini (10 shared papers)Rana R. McKay (2 shared papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Katy Beckermann
21 papers receiving 89 citations
Peers
Comparison fields: 5 of 18
- Cancer Research 38
- Pulmonary and Respiratory Medicine 63
- Oncology 28
- Molecular Biology 38
- Immunology 11
Countries citing papers authored by Katy Beckermann
This map shows the geographic impact of Katy Beckermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Beckermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Beckermann more than expected).
Fields of papers citing papers by Katy Beckermann
This network shows the impact of papers produced by Katy Beckermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Beckermann. The network helps show where Katy Beckermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Katy Beckermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 12 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 9 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2018 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2021 | 2 | |
| 17 | 2017 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 1 |
About Katy Beckermann
Katy Beckermann is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 26 papers that have together received 89 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Renal and related cancers (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Phagocytosis and Immune Regulation (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (38 citations), Pulmonary and Respiratory Medicine (63 citations), Oncology (28 citations), Molecular Biology (38 citations) and Immunology (11 citations). Katy Beckermann has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Hans J. Hammers, Toni K. Choueiri, Daniel Yick Chin Heng, Nicholas J. Vogelzang, Naomi B. Haas, Laurence Albigès, Brian I. Rini, Rana R. McKay, W. Kimryn Rathmell and Vijay Kasturi. Their work appears in journals such as Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.